https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Drugs Aging 2007;24(3):197-221
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Drugs Aging 2007;24(3):197-2212007-01-01 00:00:002019-02-15 09:24:11Advances in prostate cancer immunotherapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Thyroid 2007 Jan;17(1):53-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Thyroid 2007 Jan;17(1):53-82007-01-01 00:00:002019-02-15 08:53:25Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-812007-01-01 00:00:002007-01-01 00:00:00Gene expression in enhanced apoptosis of human lymphoma U937 cells treated with the combination of different free radical generators and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-23 / Breast Cancer Res. Treat. 2007 Nov;105(3):277-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-23 / Breast Cancer Res. Treat. 2007 Nov;105(3):277-862006-12-23 00:00:002019-02-15 08:50:18Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-19 / Biotechnol. Lett. 2007 Mar;29(3):351-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-19 / Biotechnol. Lett. 2007 Mar;29(3):351-72006-12-19 00:00:002019-02-15 09:19:44Larger numbers of immature dendritic cells augment an anti-tumor effect against established murine melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-15 / Nat. Rev. Immunol. 2007 Jan;7(1):19-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-15 / Nat. Rev. Immunol. 2007 Jan;7(1):19-302006-12-15 00:00:002019-02-15 08:44:39Steady-state and inflammatory dendritic-cell development
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Oncol. Rep. 2006 Dec;16(6):1317-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Oncol. Rep. 2006 Dec;16(6):1317-242006-12-01 00:00:002019-02-15 08:38:15Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-702006-12-01 00:00:002019-02-15 08:59:55[Dendritic cells and gliomas: a hope in immunotherapy?]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Nat. Immunol. 2006 Dec;7(12):1299-308
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Nat. Immunol. 2006 Dec;7(12):1299-3082006-12-01 00:00:002019-02-15 09:17:43Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Int. J. Hematol. 2006 Dec;84(5):449-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Int. J. Hematol. 2006 Dec;84(5):449-582006-12-01 00:00:002019-02-15 08:48:21Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells
